[{"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0173-2019", "product_description": "Prostaglandin E1 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1623-05", "product_quantity": "193 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04262018:18 Discard by: 10/22/2018; 03292018:66 Discard by: 9/24/2018; 05312018:19 Discard by: 11/27/2018; 07022018:55 Discard by: 12/29/2018; 06122018:51 Discard by: 12/9/2018; 07242018:71 Discard by: 1/20/2019; 08302018:90 Discard by: 2/23/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0064-2019", "product_description": "Walgreens, NO DRIP Severe Anefrin Nasal Spray (Oxymetazoline HCl 0.05%) Nasal Decongestant, Maximum Strength, 12 Hour + Menthol, 0.5 FL OZ (15 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-7001-01, UPC 3 11917 18536 1.", "product_quantity": "533,016 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0123-2019", "product_description": "Body Skin Tonic, Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0017-1", "product_quantity": "857 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "West Jordan", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81556", "recalling_firm": "CAO Group, Inc.", "address_1": "4628 W Skyhawk Dr", "address_2": "N/A", "postal_code": "84084-4501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0290-2019", "product_description": "fas.TRACT Coagulative Hemostatic Gel, 10% Ferric Sulfate Kit, Rx Only, (3) 3cc Preloaded Syringes/ (50) Scrub Tips. Distributed by: Benco Dental, 295 Center Point Blvd., Pittston, PA 18640. NDC: 14060-01105", "product_quantity": "115 kits", "reason_for_recall": "cGMP violations noted during the firm's most recent inspection.", "recall_initiation_date": "20181116", "center_classification_date": "20181211", "termination_date": "20200227", "report_date": "20181219", "code_info": "Lot # 170831, EXP 8/31/2019; 180704, EXP 7/04/2020"}, {"country": "United States", "city": "Malvern", "address_1": "1400 Atwater Dr", "reason_for_recall": "Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states \"Two to four tablets four times daily.\" rather than the correct dosage of \"Two tablets three times daily.\"", "address_2": "", "product_quantity": "2,856 bottles", "code_info": "Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21", "center_classification_date": "20181009", "distribution_pattern": "Nationwide in the USA.", "state": "PA", "product_description": "robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA  19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN  47274; NDC 52244-449-10.", "report_date": "20181010", "classification": "Class I", "openfda": {}, "recalling_firm": "Endo Pharmaceuticals, Inc.", "recall_number": "D-0009-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81034", "termination_date": "20200204", "more_code_info": "", "recall_initiation_date": "20180917", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0185-2019", "product_description": "Sermorelin/GHRP-2/Theanine/Mannitol 15 mg/6 mg/75 mg/300 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1731-10", "product_quantity": "108 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 07062018:05 Discard by: 1/2/2019"}, {"status": "Terminated", "city": "Neijiang", "state": "", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80892", "recalling_firm": "Sichuan Friendly Pharmaceutical Co.,Ltd.", "address_1": "No. 680 Hongpai Road", "address_2": "Dongxing", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide and China", "recall_number": "D-0006-2019", "product_description": "Thyroid Powder 25kg/drum, US Pharmacopoeia, Sichuan Friendly Pharmaceutical Co., LTD, Production Address: No. 680, Hongpai Road, Dongxing District, Neijiang City Sichuan, China Tel:+886 832 2240082/2240298. NDC 7807-0170-11", "product_quantity": "2662 kg", "reason_for_recall": "CGMP Deviations:  Thyroid Powder has inconsistent levels of the active ingredients  levothyroxine and liothyronine.", "recall_initiation_date": "20180821", "center_classification_date": "20181002", "termination_date": "20250707", "report_date": "20181010", "code_info": "All lots to include 160601, 160602, 160603, 160801, 161101, 162011, 170301, 170501, 170502, 170701, and 170702", "more_code_info": ""}, {"status": "Terminated", "city": "Lyndhurst", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81189", "recalling_firm": "Amerigen Pharmaceuticals Inc.", "address_1": "9 Polito Ave Ste 900", "address_2": "N/A", "postal_code": "07071-3410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed U.S. nationwide.", "recall_number": "D-0249-2019", "product_description": "Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDC 43975-253-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071.", "product_quantity": "5,232 bottles: a) 4,146 bottles; b) 1,086 bottles", "reason_for_recall": "Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.", "recall_initiation_date": "20181005", "center_classification_date": "20181115", "termination_date": "20190930", "report_date": "20181024", "code_info": "Lot #: a) 17F058A, Exp 6/19; b) 17F058B, Exp 6/19"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "81731", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0339-2019", "product_description": "Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle,  Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01", "product_quantity": "1996 bottles", "reason_for_recall": "Superpotent Drug.", "recall_initiation_date": "20181206", "center_classification_date": "20181218", "termination_date": "20201008", "report_date": "20181226", "code_info": "Lot #:18A18, Exp. 01/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["ECOLAB"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["Ecolab Inc."], "product_ndc": ["47593-521"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1549867"], "spl_id": ["4b51435a-39da-4b16-9497-76966b15dec6"], "spl_set_id": ["f646187a-6f78-436c-a397-7541a2c691b8"], "package_ndc": ["47593-521-59", "47593-521-41", "47593-521-56", "47593-521-38", "47593-521-57", "47593-521-70"], "is_original_packager": [true], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "81510", "recalling_firm": "Ecolab Inc", "address_1": "Level 7 370 N", "address_2": "N/A", "postal_code": "55102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0274-2019", "product_description": "Equi-Soft Foam, Antimicrobial Hand Soap, 0.55% Benzalkonium Chloride, 25 fl oz (750 mL), OTC, Ecolab, 370 Wabasha Street N, St. Paul, MN 55102,  NDC 47593-521-41", "product_quantity": "12,540 bottles", "reason_for_recall": "Labeling: Label mix-up -  the label on the product may not match the formula in the bottle.", "recall_initiation_date": "20181109", "center_classification_date": "20181120", "termination_date": "20201106", "report_date": "20181128", "code_info": "Lot# L062881, Exp 06/20, 5338HU1800, Exp 08/20", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C232 BUD: 11/3/2018; C239 BUD: 11/14/2018; C246 BUD: 11/29/2018; C260 BUD: 12/19/2018; D004 BUD: 1/4/2019; D017 BUD: 1/18/2019; D023 BUD: 1/26/2019; D053 BUD: 3/6/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 100mg pellet, 1 count (NDC 69761-110-01), 6 count (NDC 69761-110-06), 12 count (NDC 69761-110-12), and 30 count (NDC 69761-110-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0231-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80997", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1207-2018", "product_description": "Minivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 count and b) 8 count boxes, Rx only, , Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6610-8", "product_quantity": "213714 boxes of 8 patches  and 15927 boxes of 2 patches", "reason_for_recall": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20180907", "center_classification_date": "20180925", "termination_date": "20200909", "report_date": "20181003", "code_info": "a) 82200 Exp. 01/2019    b) 81637 Exp. 10/2018; 82200 Exp. 01/2019; 82293 Exp. 02/2019; 82600 Exp. 04/2019; 83027 Exp. 04/2019; 83173 Exp. 06/2019; 83396 Exp. 09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0124-2019", "product_description": "Acne Tonic Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0027-1", "product_quantity": "919 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0116-2019", "product_description": "Party Relief, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0030-1 and Tester NDC 61096-1030-1", "product_quantity": "2,956 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206111"], "brand_name": ["SYNJARDY"], "generic_name": ["EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0159", "0597-0175", "0597-0180", "0597-0168"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1664315", "1664321", "1664323", "1664325", "1664326", "1664328", "1665367", "1665369"], "spl_id": ["6424b47e-d581-4a0f-8baa-e66eee8d5902"], "spl_set_id": ["0fdd0255-0055-65f3-b2c0-db8fbb87beae"], "package_ndc": ["0597-0159-60", "0597-0159-18", "0597-0159-66", "0597-0175-60", "0597-0175-18", "0597-0175-66", "0597-0180-60", "0597-0180-18", "0597-0180-66", "0597-0168-60", "0597-0168-18", "0597-0168-66"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "786Z46389E"]}, "product_type": "Drugs", "event_id": "80961", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1217-2018", "product_description": "Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim  (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18", "product_quantity": "998 180-count bottles", "reason_for_recall": "Cross Contamination With Other Products:", "recall_initiation_date": "20180904", "center_classification_date": "20180927", "termination_date": "20190819", "report_date": "20181003", "code_info": "Lot # 603968 EXP 4/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0316-2019", "product_description": "Valsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5815-77.", "product_quantity": "25,147 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3081499, exp. date 3/2020     Lot # 3080009, exp. date 2/2020     Lot # 3080010, exp. date 2/2020     Lot # 3079205, exp. date 1/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0172-2019", "product_description": "Phosphate Buffer Solution 0.05 m Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-0912-20", "product_quantity": "1900 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06252018:63 Discard by: 12/22/2018; 07312018:35 Discard by: 1/26/2019"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0119-2019", "product_description": "Stress Relief, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0006-1 and Tester NDC 61096-1006-1", "product_quantity": "3,896 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA202843"], "brand_name": ["MONTELUKAST SODIUM"], "generic_name": ["MONTELUKAST SODIUM"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-726"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MONTELUKAST SODIUM"], "rxcui": ["200224"], "spl_id": ["30387eb8-222d-146e-e063-6294a90a12a7"], "spl_set_id": ["97a682c2-7e00-4d07-a5ac-4436c977f842"], "package_ndc": ["31722-726-30", "31722-726-90", "31722-726-01", "31722-726-10", "31722-726-31", "31722-726-32"], "is_original_packager": [true], "upc": ["0331722726306"], "unii": ["U1O3J18SFL"]}, "product_type": "Drugs", "event_id": "81029", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1213-2018", "product_description": "Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only,  By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.", "product_quantity": "98,016 bottles", "reason_for_recall": "Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.", "recall_initiation_date": "20180820", "center_classification_date": "20180926", "termination_date": "20211105", "report_date": "20181003", "code_info": "Lot #: MON17355, Exp 12/19", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0032-2019", "product_description": "CVS Health, Sterile Saline Nasal Mist (sodium chloride) Allergy & Sinus Relief, 3.0%, 4.25 OZ (126 g) can, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 41854 3.", "product_quantity": "277,587 cans", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "West Jordan", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81556", "recalling_firm": "CAO Group, Inc.", "address_1": "4628 W Skyhawk Dr", "address_2": "N/A", "postal_code": "84084-4501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0293-2019", "product_description": "FastStat Topical Hemostat Introductory Kit, 10% Ferric Sulfate 10%, Rx Only, 3-3cc preloaded syringes. CAO GROUP, INC, 4628 West Skyhawk Drive West Jordan, UT 84084. NDC 1406001003", "product_quantity": "602 cartons", "reason_for_recall": "cGMP violations noted during the firm's most recent inspection.", "recall_initiation_date": "20181116", "center_classification_date": "20181211", "termination_date": "20200227", "report_date": "20181219", "code_info": "Lot #: 170626, EXP 6/26/2019; 171214, EXP 1214/2019."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0168-2019", "product_description": "Methylcobalamin 1 mg/mL a) 10 mL Injectable NDC 69699-1501-10; b) 30 mL Injectable NDC 69699-1501-30, Pharm D Solutions, Houston, Texas", "product_quantity": "24500 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a) 04242018:27 Discard by: 9/15/2018; 04302018:55 Discard by: 10/27/2018; b) 03192018:33 Discard by: 9/15/2018; 05222018:28 Discard by: 11/18/2018"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81199", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0215-2019", "product_description": "5% Dextrose Injection, USP, Rx Only, a) 25 mL NDC 0409-7923-20; b) 250 mL NDC 0409-7922-02, Hospira, Inc. Lake Forest, IL 60045", "product_quantity": "372,912 bags", "reason_for_recall": "Lack of Assurance of Sterility; bags have the potential to leak", "recall_initiation_date": "20181008", "center_classification_date": "20181102", "termination_date": "20210308", "report_date": "20181114", "code_info": "Lots: a) 84-017-JT Exp. December 01, 2019; b) 84-012-JT Exp. June 01, 2019", "more_code_info": ""}, {"country": "United States", "city": "Princeton", "address_1": "107 College Rd E", "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS for unknown impurities.", "address_2": "", "product_quantity": "10,530 vials", "code_info": "Batch Numbers: BS704, EXP 12/018;  BS725, EXP 6/2019; BS745, EXP 11/2019.", "center_classification_date": "20181026", "distribution_pattern": "Product was distributed to retailers, distributors, physician officers and medical facilities throughout the United States.", "state": "NJ", "product_description": "Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL) One 100ml Single-Dose Bottle, Rx Only. NOVAPLUS Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. N+ and NOVAPLUS are registered trademarks of Vizient, Inc. NDC 43598-331-11", "report_date": "20181003", "classification": "Class III", "openfda": {"application_number": ["ANDA091363"], "brand_name": ["ZOLEDRONIC ACID"], "generic_name": ["ZOLEDRONIC ACID"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-331"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ZOLEDRONIC ACID"], "rxcui": ["705824"], "spl_id": ["d89899a3-8ada-0438-07b9-2164c640995a"], "spl_set_id": ["c8e02635-4473-8ba2-248f-ced58dbeabce"], "package_ndc": ["43598-331-11"], "is_original_packager": [true], "unii": ["6XC1PAD3KF"]}, "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "recall_number": "D-0104-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81012", "termination_date": "20200303", "more_code_info": "", "recall_initiation_date": "20180912", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0267-2019", "product_description": "Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90-count bottle (NDC 69367-119-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc Hauppauge, NY 11755   Manufactured for Westminister Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA", "product_quantity": "2,977 HDPE bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "69367-119-01 Irbesartan 75mg Tablets, 30 count bottle B160002A Sep-19     69367-119-03 Irbesartan 75mg Tablets, 90 count bottle B160002B Sep-19", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0152-2019", "product_description": "Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03", "product_quantity": "945 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 07272018:17 Discard by: 9/25/2018; 08292018:74 Discard by: 10/28/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0154-2019", "product_description": "Glutathione 200 mg/mL Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1504-30", "product_quantity": "4000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08012018:94 Discard by: 1/27/2019"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0306-2019", "product_description": "Amlodipine and Valsartan Tablets 10 mg/320 mg  (a) 30-count bottles (NDC 0093-7693-56) & 90-count bottles (NDC 0093-7693-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "142,260 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "NDC 0093-7693-56 & NDC 0093-7693-98  Lot # 26X036, 26X038, 26X039, 26X040, 26X041, 26X042, 26X043, 26X044, 26X045, 26X046, 26X047, 26X048, 26X049, 26X050, 26X051"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0038-2019", "product_description": "FAMILY wellness, Sterile Saline, Nasal Mist, Saline Nasal Relief (0.9% Sodium Chloride Solution), 4.25 FL OZ (126 mL) can, Distributed by: Midwood Brands, LLC, 10611 Monroe Rd., Matthews, NC 28105, UPC 0 32251 11617 9.", "product_quantity": "46,056 cans", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81413", "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "address_1": "24416 N 19th Ave", "address_2": "N/A", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide.", "recall_number": "D-0131-2019", "product_description": "Morphine (1 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38", "product_quantity": "1,360 bags", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20181019", "center_classification_date": "20181101", "termination_date": "20210506", "report_date": "20181107", "code_info": "Lot # 7/10/18 0415 24110P, Exp 11/07/2018; 7/25/18 0247 24110P, Exp 11/22/2018"}, {"status": "Terminated", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81061", "recalling_firm": "Humco Holding Group, Inc", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0024-2019", "product_description": "Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA", "product_quantity": "10 kilograms", "reason_for_recall": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "recall_initiation_date": "20180828", "center_classification_date": "20181012", "termination_date": "20200507", "report_date": "20181024", "code_info": "Lot: A26450 Exp. 05/2019"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81500", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0265-2019", "product_description": "IRBESARTAN Tablets, USP 300 mg (a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90) Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Distributed by: GSMS, Incorporated, Camarillo, CA 93012, USA.", "product_quantity": "12,502 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.", "recall_initiation_date": "20181102", "center_classification_date": "20181120", "termination_date": "20200916", "report_date": "20181128", "code_info": "Lot Numbers: 30-count bottles  GS019036; Exp 09/19  GS019073; Exp. 09/19  GS021472; Exp. 11/19  GS021530; Exp. 11/19  GS022234; Exp. 02/20    90-count bottles  B162009; Exp. 09/19  B162010; Exp. 09/19  B162011; Exp. 09/19  B162012; Exp. 11/19  B162013; Exp. 11/19  B162014; Exp. 11/19  B162015; Exp. 11/19  C162001; Exp. 02/20", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lot: C254 BUD: 12/13/2018", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 200 mg/Anastrozole 20 mg pellet, 1 count (NDC 69761-222-01), 6 count (NDC 69761-222-06), 12 count (NDC 69761-222-12), and 30 count (NDC 69761-222-30) vials, Rx Only, Qualgen, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0238-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0077-2019", "product_description": "Rexall, Extra Moisturizing No Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) 1 FL OZ (30 mL) bottle, 48/3/1 #12687901 w/ Silo", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81413", "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "address_1": "24416 N 19th Ave", "address_2": "N/A", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide.", "recall_number": "D-0135-2019", "product_description": "Phenylephrine 30 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38", "product_quantity": "300 bags", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20181019", "center_classification_date": "20181101", "termination_date": "20210506", "report_date": "20181107", "code_info": "Lot# 138-20180409@55, Exp 11/18/2018"}, {"status": "Terminated", "city": "Marlborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018956"], "brand_name": ["OMNIPAQUE"], "generic_name": ["IOHEXOL"], "manufacturer_name": ["GE Healthcare Inc."], "product_ndc": ["0407-1401", "0407-1411", "0407-1412", "0407-1413", "0407-1414", "0407-1415", "0407-1416"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVASCULAR", "INTRAVENOUS"], "substance_name": ["IOHEXOL"], "spl_id": ["5bd452ab-2645-4f2d-8f53-2e984ee231b4"], "spl_set_id": ["eee15ebe-d349-4497-acef-6abe7a8247fb"], "package_ndc": ["0407-1401-52", "0407-1411-10", "0407-1411-20", "0407-1412-10", "0407-1412-20", "0407-1412-50", "0407-1412-29", "0407-1412-30", "0407-1412-60", "0407-1412-33", "0407-1412-27", "0407-1412-49", "0407-1412-34", "0407-1412-28", "0407-1412-35", "0407-1413-11", "0407-1413-10", "0407-1413-59", "0407-1413-30", "0407-1413-50", "0407-1413-51", "0407-1413-61", "0407-1413-95", "0407-1413-98", "0407-1413-62", "0407-1413-99", "0407-1413-60", "0407-1413-63", "0407-1413-91", "0407-1413-53", "0407-1413-90", "0407-1413-65", "0407-1413-92", "0407-1413-66", "0407-1413-93", "0407-1413-96", "0407-1413-69", "0407-1414-21", "0407-1414-50", "0407-1414-51", "0407-1414-52", "0407-1414-89", "0407-1414-20", "0407-1414-90", "0407-1414-22", "0407-1414-53", "0407-1414-60", "0407-1414-91", "0407-1414-76", "0407-1414-03", "0407-1414-23", "0407-1414-93", "0407-1414-04", "0407-1414-94", "0407-1414-24", "0407-1414-80", "0407-1414-95", "0407-1415-09", "0407-1416-12"], "is_original_packager": [true], "nui": ["N0000180185", "N0000010258"], "pharm_class_epc": ["Radiographic Contrast Agent [EPC]"], "pharm_class_moa": ["X-Ray Contrast Activity [MoA]"], "unii": ["4419T9MX03"]}, "product_type": "Drugs", "event_id": "81691", "recalling_firm": "GE Healthcare Inc. Life Sciences", "address_1": "100 Results Way", "address_2": "", "postal_code": "01752-3078", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TN", "recall_number": "D-0319-2019", "product_description": "Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.", "product_quantity": "1092 cartons", "reason_for_recall": "Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.", "recall_initiation_date": "20181029", "center_classification_date": "20181214", "termination_date": "20231030", "report_date": "20181226", "code_info": "Lot #: 14301544, Exp 21Sep21", "more_code_info": ""}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0326-2019", "product_description": "Valsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5814-77.", "product_quantity": "232,180 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers: 3069019,  3069020, 3069021, 3069022, 3071354, 3071355,    3071357    3079023    3079027    3079028    3079029    3079996  3079997    3079998    3083635    3086715    3086716    3086717  3088623"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0136-2019", "product_description": "Acetylcysteine Injection 10 mg/5 mL (2 mg/mL), Pharm D Solutions, Houston, Texas ---- NDC 69699-1424-10", "product_quantity": "486 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 07032018:93 Discard by: 01/03/2019; 07032018:27 Discard by: 01/03/2019; 07032018:97 Discard by: 01/03/2019"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0138-2019", "product_description": "Ascorbic Acid 500 mg/mL Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1502-50", "product_quantity": "10000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04252018:91 Discard by: 10/21/2018"}, {"country": "United States", "city": "Glendale", "address_1": "655 N Central Ave Fl 17 Ste 1704a", "reason_for_recall": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "address_2": "", "product_quantity": "8 kgs", "code_info": "Lot # 170501", "center_classification_date": "20181005", "distribution_pattern": "Distributed to two compounding firms in Minnesota.", "state": "CA", "product_description": "Thyroid powder, 4.5 kg foil bag, 5x1 kg foil bags packed in 25 Kg Fiber Drum, Thyroid Powder 25kg/drum, US Pharmacopoeia, Sichuan Friendly Pharmaceutical Co., LTD, Production Address: No. 680, Hongpai Road, Dongxing District, Neijiang City Sichuan, China Tel:+886 832 2240082/2240298, NDC 7807-0170-11", "report_date": "20181017", "classification": "Class II", "openfda": {}, "recalling_firm": "Alkano Chemicals, Inc", "recall_number": "D-0008-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81147", "termination_date": "20190221", "more_code_info": "", "recall_initiation_date": "20180830", "postal_code": "91203-1439", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0208-2019", "product_description": "Trimix T-106 30PA-1PH-25A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1339-05", "product_quantity": "44 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03292018:66 Discard by: 9/24/2018; 05312018:81 Discard by: 11/27/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0202-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil/Lidocaine 30 mg/1 mg/175 mcg/1 mg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1369-02", "product_quantity": "195 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05302018:59 Discard by: 11/26/2018; 06132018:44 Discard by: 12/10/2018; 06062018:64 Discard by: 12/3/2018; 07262018:97 Discard by: 11/1/2018; 07052018:23 Discard by: 1/1/2019"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0206-2019", "product_description": "Trimix ST9D 30PA-2PH-150A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1311-03", "product_quantity": "336 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04102018:12 Discard by: 10/7/2018; 05102018:06 Discard by: 11/6/2018; 05222018:76 Discard by: 11/18/2018; 07022018:35 Discard by: 12/29/2018; 08272018:00 Discard by: 1/14/2019; 08082018:14 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0115-2019", "product_description": "TravelEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879NDC 61096-0007-1. and Tester NDC 61096-1007-1", "product_quantity": "1,307 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0112-2019", "product_description": "Cold + Flu Relief, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0002-1", "product_quantity": "2,565 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0271-2019", "product_description": "GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.", "product_quantity": "18,760 HDPE bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "60429-641-90 Irbesartan 150mg Tablets, 90 Count Bottle    B161003 Sep-19   B161004 Sep-19   B161006 Sep-19   B161007 Sep-19   B161008 Nov-19   B161009 Nov-19   B161010 Nov-19   C161001 Feb-20   C161003 May-20           60429-641-30 Irbesartan 150mg Tablets, 30 Count Bottle   GS019526 Nov-19   GS020252 Nov-19   GS020958 Nov-19", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0042-2019", "product_description": "Meijer, Sterile Saline Nasal Mist (0.9% Sodium Chloride Solution), 4.25 OZ (120 g) can, Dist. By Meijer Distribution, Inc., 2929 Walker Ave. NW, Grand Rapids, MI 49544, UPC 7 13733 27615 3.", "product_quantity": "37,464 cans", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078950"], "brand_name": ["METOPROLOL"], "generic_name": ["METOPROLOL TARTRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-033"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["METOPROLOL TARTRATE"], "rxcui": ["866508"], "spl_id": ["5d975af3-d078-4130-9448-ed77123f1aac"], "spl_set_id": ["09566368-f91d-43a3-b683-30c844fb125a"], "package_ndc": ["36000-033-10"], "is_original_packager": [true], "upc": ["0336000033107"], "unii": ["W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "81353", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide in the USA and Puerto Rico", "recall_number": "D-0222-2019", "product_description": "Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, Manufactured for: Claris Lifesciences, Inc., North Brunswick, NJ 08902.  By:  Claris Injectables Ltd., Gujarat, India.  NDC:  36000-033-10", "product_quantity": "402,165 vials", "reason_for_recall": "Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.", "recall_initiation_date": "20181015", "center_classification_date": "20181107", "termination_date": "20220812", "report_date": "20181114", "code_info": "Lot #S: A061267, A061273,EXP 10/2018; A061392, A061395, A061398, A061403, A061407, EXP 11/2018; A0A0070, A0A0073, A0A0079, A0A0081, A0A0083, EXP 12/2018; A0A0119, A0A0124, A0A0125, A0A0133, A0A0141, A0A0145, A0A0152, EXP 1/2019; A0A0247, A0A0252, A0A0253, A0A0292, A0A0293, EXP 2/2019; A0A0361, A0A0367, A0A0390, EXP 3/2019; A0A0438, A0A0445, A0A0453, A0A0459, EXP 4/2019; A0A0547, A0A0551, A0A0554, A0A0630, A0A0631, A0A0637, A0A0638, EXP 5/2019; A0A0777, EXP 7/2019; A0A0915, A0A0919, A0A0924, A0A0930, EXP 8/2019; A0A1094, A0A1097, A0A1110, EXP 11/2019;", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091023"], "brand_name": ["CLOPIDOGREL BISULFATE"], "generic_name": ["CLOPIDOGREL BISULFATE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-671"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOPIDOGREL BISULFATE"], "rxcui": ["749196"], "spl_id": ["e74780f8-a035-e6a0-b457-c04edd4162bf"], "spl_set_id": ["4da4da53-91ae-4d4f-145f-255c5db443a5"], "package_ndc": ["55111-671-30", "55111-671-90", "55111-671-01", "55111-671-05", "55111-671-48", "55111-671-79", "55111-671-81", "55111-671-06", "55111-671-31", "55111-671-78"], "is_original_packager": [true], "unii": ["08I79HTP27"]}, "product_type": "Drugs", "event_id": "81530", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A.nationwide", "recall_number": "D-0283-2019", "product_description": "Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31", "product_quantity": "4,212 (30-count blister pack)", "reason_for_recall": "Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.", "recall_initiation_date": "20181107", "center_classification_date": "20181127", "termination_date": "20200519", "report_date": "20181128", "code_info": "Lot #: T600530, Exp 11/18", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0213-2019", "product_description": "Testosterone in Grapeseed Oil 200 mg/mL, a) 4 mL, b) 5 mL, c) 10 mL and d) 30 mL Injectable, Pharm D Solutions, Houston, Texas NDC 69699-1702-05", "product_quantity": "a) 4397, b) 4885 c) 1319, d) 4112 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a)  Lot: 01302018:77/A Discard by: 1/25/2019; 09042017:74/B Discard by: 8/30/2018; 04042018:51/A Discard by: 3/31/2019; 05152018:94/A Discard by: 5/9/2019; 07022018:04/A Discard by: 6/27/2019; 07162018:80/B Discard by: 7/11/2019; 08272018:15/B Discard by: 8/22/2019; b) 12052017:13/B, Discard by: 11/30/2018; 09042017:74/A Discard by: 8/30/2018; 03212018:39/B Discard by: 3/17/2019; 01302018:77/B Discard by: 1/25/2019; 06262018:25/A Discard by: 6/21/2019; 05212018:45/A Discard by: 5/16/2019; 05152018:94/B Discard by: 5/9/2019; 07162018:80/A Discard by: 7/11/2019 c)  Lot: 09132017:58/A Discard by: 9/7/2018; 03212018:39/P Discard by: 3/16/2019; 05012018:45/A Discard by: 4/26/2019; 05012018:45/P Discard by: 4/26/2019; 06042018:58/A Discard by: 5/30/2019; 05152018:94/C Discard by: 5/9/2019; 07022018:04/B Discard by: 6/27/2019 d)  Lot: 01082018:40/B Discard by: 1/3/2019; 09042017:74/C Discard by: 8/30/2018; 09132017:58/B Discard by: 9/7/2018; 01302018:77/C Discard by: 1/25/2019; 03212018:39/C Discard by: 3/16/2019; 04042018:51/B Discard by: 3/30/2019; 06042018:58/B Discard by: 5/30/2019; 05012018:45/B Discard by: 4/26/2019; 06132018:02/B Discard by: 6/3/2019; 05212018:94/B Discard by: 5/9/2019; 05152018:94/D Discard by: 5/9/2019; 07162018:80/C Discard by: 7/11/2019; 08062018:67A Discard by: 8/1/2019; 07022018:04/C Discard by: 6/27/2019; 07242018:04/A Discard by: 7/19/2019; 08272018:15/A Discard by: 8/22/2019"}, {"country": "United States", "city": "Hawthorne", "address_1": "3 Skyline Dr", "reason_for_recall": "Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.", "address_2": "", "product_quantity": "", "code_info": "Lot # 313344, Exp 12/18", "center_classification_date": "20181120", "distribution_pattern": "Nationwide in the USA", "state": "NY", "product_description": "children's allergy relief (cetirizine hydrochloride) oral solution, 1 mg/mL, Dye Free, Sugar Free, Alcohol Free, 4 FL OZ (120 mL) bottle, Distributed by Rite-Aid, 30 Hunter Lane, Camp Hill, PA 17011, Made in Israel, UPC 0 11822 57363 4.", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "recall_number": "D-0278-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81483", "termination_date": "20201103", "more_code_info": "", "recall_initiation_date": "20181019", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0182-2019", "product_description": "Sermorelin/GHRP-2 9 mg-6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1728-10", "product_quantity": "330 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03202018:06 Discard by: 9/16/2018; 06112018:49 Discard by: 12/8/2018"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80997", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1210-2018", "product_description": "Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6675-8", "product_quantity": "74908 boxes of 8 patches", "reason_for_recall": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20180907", "center_classification_date": "20180925", "termination_date": "20200909", "report_date": "20181003", "code_info": "Lots: 82599 Exp. 05/2019; 82660 Exp. 03/2019; 83396 Exp. 09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0178-2019", "product_description": "Reck Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1459-50", "product_quantity": "517 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03262018:11 Discard by: 4/25/2018; 04102018:38 Discard by: 5/10/2018; 05312018:63 Discard by: 6/30/2018; 05032018:97 Discard by: 6/2/2018; 06082018:24 Discard by: 7/8/2018; 05212018:80 Discard by: 6/20/2018; 07102018:60 Discard by: 8/9/2018; 06202018:44 Discard by: 7/19/2018; 07232018:08 Discard by: 8/22/2018; 07022018:62 Discard by: 8/1/2018; 08292018:95 Discard by: 9/28/2018; 08202018:61 Discard by: 9/19/2018"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C255 BUD: 12/13/2018", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 18mg pellet, 1 count (NDC 69761-018-01), 6 count (NDC 69761-018-06), 12 count (NDC 69761-018-12), and 30 count (NDC 69761-018-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0228-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Titusville", "address_1": "1125 Trenton-Harbourton Rd.", "reason_for_recall": "Labeling: Incorrect Instructions; Instructions included  for use with the Veridate dispenser contained instructions for the Dialpak dispenser.", "address_2": "", "product_quantity": "a) 3,956 cartons; b) 1 carton", "code_info": "Lot #: a) 18CM120, Exp 03/2020; b) 18BM110, Exp. 03/2020", "center_classification_date": "20181106", "distribution_pattern": "Nationwide in the USA", "state": "NJ", "product_description": "Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035, 28-Day Regimen per pouch, packaged in a) 6 Veridate Tablet Dispensers and 6 Refill pouches (NDC 504-58-178-28) per carton (NDC 50458-178-06); and b) 12 Veridate Tablet Dispenser Refills (NDC 50458-178-12) per carton (NDC 50458-178-12), Clinic Package, , Rx Only, Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674; Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560.", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Janssen Pharmaceuticals, Inc.", "recall_number": "D-0218-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81289", "termination_date": "20191030", "more_code_info": "", "recall_initiation_date": "20181023", "postal_code": "08560", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0180-2019", "product_description": "Sermorelin/GHRP-2 6 mg/6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1727-10", "product_quantity": "409 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05012018:48 Discard by: 10/28/2018; 05242018:32 Discard by: 11/20/2018; 06112018:53 Discard by: 12/8/2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0031-2019", "product_description": "CVS Health, Saline Nasal Spray, Nasal Moisturizing Spray, Contains: Sodium Chloride 0.65%, Benzyl Alcohol & Benzalkonium Chloride as Preservatives, 1.5 FL OZ (44 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 40814 8 Product #891465.", "product_quantity": "552 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0164-2019", "product_description": "HCG 6000 unit/0.3 gm Mannitol Lyopholized 6000 IU/vial injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1739-06", "product_quantity": "442 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04092018:14 Discard by: 10/6/2018; 06042018:54 Discard by: 12/1/2018; 05292018:81 Discard by: 11/25/2018"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0268-2019", "product_description": "Westminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-120-01), (b) 90-count bottle (NDC 69367-120-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755, Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854, Made in the USA.", "product_quantity": "5,061 HDPE bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "69367-120-01 Irbesartan 150mg Tablets, 30 count bottle   B161005A Sep-19   C161002A Feb-20   69367-120-03 Irbesartan 150mg Tablets, 90 count bottle  B161005B Sep-19   C161002B Feb-20", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0169-2019", "product_description": "Oxytocin 30 unit in LR 500 mL 0.06 units/mL IV,Pharm D Solutions, Houston, Texas ---  NDC 69699-1203-50", "product_quantity": "264 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03152018:12 Discard by: 6/13/2018; 04182018:08 Discard by: 7/17/2018; 04302018:94 Discard by: 7/29/2018; 03292018:44 Discard by: 6/26/2018; 05212018:95 Discard by: 8/19/2018; 06142018:46 Discard by: 9/12/2018; 05312018:37 Discard by: 8/29/2018; 06282018:80 Discard by: 9/26/2018; 07312018:12 Discard by: 10/29/2018; 07102018:53 Discard by: 10/8/2018; 08222018:18 Discard by: 11/20/2018"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0105-2019", "product_description": "Rejuvenation Plus, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879  NDC 61096-0035-1", "product_quantity": "1,558 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81741", "recalling_firm": "Asclemed USA Inc. dba Enovachem", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Natonwide", "recall_number": "D-0354-2019", "product_description": "Dyural-80 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-0755-01", "product_quantity": "", "reason_for_recall": "Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex", "recall_initiation_date": "20181211", "center_classification_date": "20190109", "termination_date": "20230201", "report_date": "20181226", "code_info": "Lot # 050918X1, 051618X10, 051818X4, Exp 12/31/18; 071718X2, Exp 2/28/19; 061118X8, Exp 5/1/19; 051518X4, 051818X5, 052118X4, 052118X5, 052918X7, 061118X9, 061118X10, 061418X2, 061518X1, Exp 5/31/19; 061518X2, 061918X2, 062518X2, 062718X1, 062718X2, 062818X3, 062818X4, 070918X1, 071018X5, 071118X4, 071118X5, 072018X6, 072418X3, 072418X4, 072518X2, 073018X4, 073018X8, 080218X3, 080718X7, 080918X3, 083018X2, 083118X2, 083118X5, 090518X5, Exp 6/30/2019; 090518X6, 090718X2, 090718X3, 090718X5, 091118X7, 091318X5, 091918X1, 092718X1, 092718X2, 092818X3, 100518X6, 101118X3, 101518X2, 101618X7, 101618X8, 101818X3, 101918X1, 102318X1, 103118X1, 103118X2, Exp 7/31/19; 103118X3, 110618X1, 110818X1, Exp 9/30/19", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0145-2019", "product_description": "Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1428-02", "product_quantity": "567 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 07192018:88 Discard by: 10/16/2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0075-2019", "product_description": "Rhinall Nasal Decongestant Nasal Spray (phenylephrine HCl), 0.25%, 1 1/3 Fl Oz. (40 ml), Manufactured for: Scherer Laboratories, Inc., Atlanta, GA  30339.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0068-2019", "product_description": "Premier Value, Fast Relief, Muscle Rub, (menthol 10% and methyl salicylate 15%) 4 OZ (113 g) tube, Distributed By: Chain Drug Consortium, 3301 NW Boca Raton Blvd., Suite 101, Boca Raton, FL, 33431, UPC 8 40986 01341", "product_quantity": "4,692 tubes", "reason_for_recall": "Superpotent Drug: high out of specification assay results for the menthol ingredient.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot. 172598G, Exp. 7/4/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0055-2019", "product_description": "OCEAN Saline Nasal Spray, packaged in a) 3.5 Fl. Oz. (104 mL) bottle UPC 3 01875 26001 9; b) 45 cc (1.5 fl. oz.) UPC 3 01875 26003 3, c) Buddy Pack containing one 1.5 FL. OZ. (44 mL) and one 0.76 FL.OZ. (22 mL) bottle per carton, Distributed by: Valeant Consumer Products, A Division of Valeant Pharmaceuticals, North America LLC, Bridgewater, NJ 08807.", "product_quantity": "3,442,536 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "95 bottles", "code_info": "Lot K051818A", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Native Remedies HypoSlim Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-275-02", "report_date": "20181114", "classification": "Class I", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0252-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Princeton", "address_1": "100 College Rd W", "reason_for_recall": "Cross Contamination with Other Products", "address_2": "", "product_quantity": "1550 bottles", "code_info": "Lot #: JA9534, Exp. 05/2021", "center_classification_date": "20181120", "distribution_pattern": "Nationwide within the United States", "state": "NJ", "product_description": "Isosorbide Dinitrate Tablets, USP 20 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-222-00", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Sandoz Inc", "recall_number": "D-0261-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81457", "termination_date": "20201002", "more_code_info": "", "recall_initiation_date": "20181102", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81485", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "N/A", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH, PR", "recall_number": "D-0359-2019", "product_description": "Sandoz Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg,  1000-count bottles, Rx Only, Finished Drug Product Manufactured by:  Lek Pharmaceuticals d.d. SI-1526 Ljubljana,Sovenia for Sandoz Inc., Princeton, NJ   08540, NDC 0781-5207-10.", "product_quantity": "170 HDPE bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product above  the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20181101", "center_classification_date": "20190114", "report_date": "20181205", "code_info": "Lot #: JB8912; Exp. 06/2020"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0097-2019", "product_description": "Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC 0591-3695-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054", "product_quantity": "3,785 bottles", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Lot #: a) 1291192A, Exp 01/2020; b) 1291193A, Exp 01/2020"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0121-2019", "product_description": "Life Detoxer Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879NDC 61096-0023-1 and Tester NDC 61096-1023-1", "product_quantity": "1,473 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81413", "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "address_1": "24416 N 19th Ave", "address_2": "N/A", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide.", "recall_number": "D-0132-2019", "product_description": "Fentanyl (10 mcg/mL) in NS 1 mL (in 3mL BD Syringe), Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38", "product_quantity": "20 syringes", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20181019", "center_classification_date": "20181101", "termination_date": "20210506", "report_date": "20181107", "code_info": "Lot # 8/8/18 0200 15-21070S, Exp 11/06/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0165-2019", "product_description": "Levocarnitine 170 mg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-10", "product_quantity": "3000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04232018:63 Discard by: 10/20/2018"}, {"country": "United States", "city": "Hawthorne", "address_1": "3 Skyline Dr", "reason_for_recall": "Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.", "address_2": "", "product_quantity": "12,432 bottles", "code_info": "Lot # 313342, Exp 12/18", "center_classification_date": "20181120", "distribution_pattern": "Nationwide in the USA", "state": "NY", "product_description": "Children's 24 Hour Allergy (cetirizine hydrochloride) Oral Solution 1 mg/mL, Bubble Gum Flavor, Sugar Free/Dye Free, 4 FL OZ (120 mL) bottle, Dist. by Meijer Distribution, Inc., Grand Rapids, MI 40644, NDC 41250-106-08, UPC 7 13733 88578 2.", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "recall_number": "D-0276-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81483", "termination_date": "20201103", "more_code_info": "", "recall_initiation_date": "20181019", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81004", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0085-2019", "product_description": "Cortaid Maximum Strength Cream (1% hydrocortisone), 1 OZ (28 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875521011", "product_quantity": "119,594 tubes", "reason_for_recall": "CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.", "recall_initiation_date": "20180824", "center_classification_date": "20181022", "termination_date": "20200306", "report_date": "20181031", "code_info": "Lot #: 170843B, Exp 2/19; 171484D, Exp 4/19; 171791E, 171848E, Exp 5/19; 172359J, 172360J, 173184J, Exp 9/19; 173512P, Exp 12/19; 180180B, Exp 2/20; 181098C, Exp 3/20"}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81340", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "N/A", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide in the USA and Puerto Rico", "recall_number": "D-0128-2019", "product_description": "Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01", "product_quantity": "1,380 100-count bottles", "reason_for_recall": "Failed Dissolution Specifications: OOS resultsduring routine stability testing", "recall_initiation_date": "20181022", "center_classification_date": "20181101", "termination_date": "20230403", "report_date": "20181107", "code_info": "Lot: 757739, EXP 9/2020"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81326", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide including Puerto Rico.", "recall_number": "D-0129-2019", "product_description": "Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01", "product_quantity": "53,451 bottles", "reason_for_recall": "Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.", "recall_initiation_date": "20181019", "center_classification_date": "20181101", "termination_date": "20190403", "report_date": "20181031", "code_info": "Lot # 1220211M, Exp 02/2019"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0270-2019", "product_description": "GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Marketed by: GSMS Incorporated Camarillo, CA 93012 USA, NDC 60429-640-90.", "product_quantity": "3,835 HDPE bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "60429-640-90 Irbesartan 75mg Tablets, 90 Count Bottle B160003 Sep-19   B160004 Sep-19", "more_code_info": ""}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "79842", "recalling_firm": "Epic Products, LLC", "address_1": "11730 W 135th St", "address_2": "#224", "postal_code": "66221-9395", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0288-2019", "product_description": "Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3.", "product_quantity": "a) 106,329 cards; b) 109,725 bottles; c) 28,644 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.", "recall_initiation_date": "20180416", "center_classification_date": "20181130", "termination_date": "20241003", "report_date": "20181121", "code_info": "All lots", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C245 BUD: 11/28/2018; D005 BUD: 1/5/2019; D027 BUD: 1/31/2019; D035 BUD: 2/9/2019; D058 BUD: 3/9/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 37.5 mg pellet, 1 count (NDC 69761-137-01), 6 count (NDC 69761-137-06), 12 count (NDC 69761-137-12) and 30 count (NDC 69761-137-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0235-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0034-2019", "product_description": "CVS Health, Saline Nasal Gel with Soothing Aloe, packaged as a) Baby Net Wt. 0.5 OZ (14.2 g) tube UPC 0 50428 58392 0 Product #282476; and b) Net Wt. 0.5 OZ tube (14.2 g) UPC 0 50428 31746 4 Product #896071; Distributed by CVS Pharmacy, Inc,. One CVS Drive, Woonsocket, RI 02895.", "product_quantity": "285,840 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0071-2019", "product_description": "CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate 5%, octocrylene 10%, Net Wt. 0.15 oz. (4.25 g) stick, CeraVe LLC., New York, NY 10001, UPC 3 01872 49201 7.", "product_quantity": "25,596 sticks", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: PSP85W/172792H"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0037-2019", "product_description": "DG health, No Drip, Nasal Pump Mist (oxymetazoline hydrochloride), 0.05%, 1 FL OZ (30 mL) bottle, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37072, UPC 7 27510 00373 3 .", "product_quantity": "786,720 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Product", "address_2": "", "product_quantity": "931 bottles", "code_info": "Lot K022317A and K022317B", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Native Remedies EyeClear Pro Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-151-59", "report_date": "20181114", "classification": "Class I", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0254-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA211913"], "brand_name": ["ABSORICA LD"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["10631-002", "10631-115", "10631-116", "10631-117", "10631-118", "10631-133", "10631-134", "10631-003", "10631-004", "10631-005", "10631-006", "10631-007"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1299203", "1300006", "1300014", "1300016", "1547561", "1547563", "1547565", "1547567", "2262711", "2262713", "2262714", "2262715", "2262717", "2262719", "2262721", "2262723", "2262725", "2262727", "2262729", "2262731"], "spl_id": ["fba81535-0761-42a7-b422-338f8bd2cfc6"], "spl_set_id": ["3ef0cff8-19c1-4441-b780-fca6c7ee1615"], "package_ndc": ["10631-115-69", "10631-115-31", "10631-116-69", "10631-116-31", "10631-117-69", "10631-117-31", "10631-118-69", "10631-118-31", "10631-133-69", "10631-133-31", "10631-134-69", "10631-134-31", "10631-002-31", "10631-003-31", "10631-004-31", "10631-005-31", "10631-006-31", "10631-007-31", "3106311173"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"], "upc": ["310631117313"]}, "product_type": "Drugs", "event_id": "81765", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1207-2019", "product_description": "Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs)  Rx only, Manufactured by:  Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton)  NDC10631-117-69 (prescription pack)", "product_quantity": "47,520 prescription packs", "reason_for_recall": "Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.", "recall_initiation_date": "20181207", "center_classification_date": "20190422", "termination_date": "20190614", "report_date": "20181226", "code_info": "Lot: 17F28AA, Exp 1/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0043-2019", "product_description": "HuMist Saline Nasal Mist 1.5 FL OZ (45 mL) bottle, Distributed by: Scherer Labs International, LLC. 330 Carswell Ave., Daytona Beach, FL 32117, UPC 3 02742 68045 9 .", "product_quantity": "3264 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091023"], "brand_name": ["CLOPIDOGREL BISULFATE"], "generic_name": ["CLOPIDOGREL BISULFATE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-671"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOPIDOGREL BISULFATE"], "rxcui": ["749196"], "spl_id": ["e74780f8-a035-e6a0-b457-c04edd4162bf"], "spl_set_id": ["4da4da53-91ae-4d4f-145f-255c5db443a5"], "package_ndc": ["55111-671-30", "55111-671-90", "55111-671-01", "55111-671-05", "55111-671-48", "55111-671-79", "55111-671-81", "55111-671-06", "55111-671-31", "55111-671-78"], "is_original_packager": [true], "unii": ["08I79HTP27"]}, "product_type": "Drugs", "event_id": "81748", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 4 major distributors who distributed the product throughout the United States.", "recall_number": "D-0294-2019", "product_description": "Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31", "product_quantity": "4,404 (30 count blister packs)", "reason_for_recall": "Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.", "recall_initiation_date": "20181210", "center_classification_date": "20181211", "termination_date": "20200625", "report_date": "20181219", "code_info": "Lot #: T700423, Exp 08/2019; T800310, Exp 03/2020"}, {"country": "United States", "city": "Orem", "address_1": "1272 S 1380 W", "reason_for_recall": "Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver", "address_2": "", "product_quantity": "10,297 bottles", "code_info": "All Lots", "center_classification_date": "20190114", "distribution_pattern": "Nationwide within the United States", "state": "UT", "product_description": "Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4", "report_date": "20181226", "classification": "Class I", "openfda": {}, "recalling_firm": "Results RNA, LLC", "recall_number": "D-0360-2019", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "81742", "termination_date": "20210129", "more_code_info": "", "recall_initiation_date": "20181214", "postal_code": "84058-4911", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0205-2019", "product_description": "Phentolamine 1 mg/Papaverine 15 mg/Alprostadil 150 mcg Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1308-03", "product_quantity": "343 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04102018:07 Discard by: 10/7/2018; 05102018:18 Discard by: 11/6/2018; 05222018:64 Discard by: 8/1/2018; 07022018:46 Discard by: 12/29/2018; 08012018:81 Discard by: 1/28/2019; 06202018:97 Discard by: 9/17/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0204-2019", "product_description": "Trimix ST-9B 30 PA-2PH-100A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1344-05", "product_quantity": "59 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04262018:54 Discard by: 10/23/2018; 03292018:91 Discard by: 9/24/2018; 05312018:10 Discard by: 11/27/2018"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0107-2019", "product_description": "Brain Power,Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0033-1", "product_quantity": "2,054 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Gainesville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80838", "recalling_firm": "Westlab Pharmacy, Inc. dba Westlab Pharmacy", "address_1": "4410 W Newberry Rd Ste A5", "address_2": "N/A", "postal_code": "32607-2290", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0090-2019", "product_description": "ADAA Cataract Drops, (Lido 1.47%, Phenyleph 0.294% Cyclopentolate 0.147%, Tropicamide 0.0735%, Moxiflox 0.0294%, Ketorolac 0.0147%) 1x 1cc syringe, Westlab Pharmacy, Inc., Gainesville, FL 32607 --- NDC 10002-2579-05", "product_quantity": "222 syringes", "reason_for_recall": "Lack of Process Controls", "recall_initiation_date": "20180810", "center_classification_date": "20181024", "termination_date": "20200507", "report_date": "20181031", "code_info": "Lot: 06182018@30 Exp. 08/28/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0140-2019", "product_description": "Bacteriostatic Water for Injection 10 mL, Pharm D Solutions, Houston, Texas --- NDC 69699-1417-10", "product_quantity": "285 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 07182018:12 Discard by: 1/14/2019; 04042018:68 Discard by: 9/30/2018; 05152018:57 Discard by: 11/10/2018; 06202018:17 Discard by: 12/17/2018"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0099-2019", "product_description": "Metformin Hydrochloride Extended Release Tablets, 500 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories, FL Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 00591-2411-01", "product_quantity": "3,397 bottles", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Lot #: 1210888A, Exp 03/2019"}, {"status": "Terminated", "city": "Laurelton", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040275"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["EPIC PHARMA, LLC"], "product_ndc": ["42806-087", "42806-088", "42806-089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["197657", "197658", "197659"], "spl_id": ["2b205859-076c-1703-e063-6394a90ac140"], "spl_set_id": ["9333d92f-2585-4b99-aaea-87c01c95125e"], "package_ndc": ["42806-087-01", "42806-087-05", "42806-088-01", "42806-088-05", "42806-089-09", "42806-089-01", "42806-089-05"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "81729", "recalling_firm": "Epic Pharma, LLC", "address_1": "22715 N Conduit Ave", "address_2": "", "postal_code": "11413-3134", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0297-2019", "product_description": "Estradiol Tablets, USP, 2 mg, 100-count bottle, Rx Only, Distributed by: Epic Pharma, LLC Laurelton, NY 11413, NDC 42806-089-01", "product_quantity": "2976 bottles", "reason_for_recall": "Presence of foreign tablet/capsule: A single foreign tablet was found in pharmacy dispensed bottle of 30 Estradiol 2 mg tablets.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "termination_date": "20210209", "report_date": "20181226", "code_info": "Lot #: 18103A, Exp 6/20", "more_code_info": ""}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA125084"], "brand_name": ["ERBITUX"], "generic_name": ["CETUXIMAB"], "manufacturer_name": ["ImClone LLC"], "product_ndc": ["66733-948", "66733-958"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CETUXIMAB"], "rxcui": ["1657658", "1657660", "1657663", "1657664"], "spl_id": ["f38a33cd-25c7-4d86-8f3c-e3168b6c2b48"], "spl_set_id": ["8bc6397e-4bd8-4d37-a007-a327e4da34d9"], "package_ndc": ["66733-948-23", "66733-958-23"], "is_original_packager": [true], "nui": ["N0000175664", "N0000020010"], "pharm_class_epc": ["Epidermal Growth Factor Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER1 Antagonists [MoA]"], "unii": ["PQX0D8J21J"]}, "product_type": "Drugs", "event_id": "81511", "recalling_firm": "Eli Lilly & Co", "address_1": "1 Lilly Corporate Ctr", "address_2": "", "postal_code": "46285-0001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, AZ, CA, KS, LA, MS, OH, OR, TN, TX and Puerto Rico", "recall_number": "D-0248-2019", "product_description": "ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by:  ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA.  NDC: 66733-958-23", "product_quantity": "9,380 vials", "reason_for_recall": "Labeling: Missing label; potential for missing primary container label on the vial.", "recall_initiation_date": "20181108", "center_classification_date": "20181115", "termination_date": "20200422", "report_date": "20181121", "code_info": "Lot number: C1700167, exp 9/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0159-2019", "product_description": "HCG 10,000 unit/0.3 gm Mannitol Lyopholized, Pharm D Solutions, Houston, Texas ---- NDC 69699-1711-10", "product_quantity": "1171 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04182018:46 Discard by: 10/14/2018; 06072018:65 Discard by: 12/3/2018; 05082018:01 Discard by: 11/4/2018; 07282018:20 Discard by: 1/24/2019"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0310-2019", "product_description": "Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/320 mg/25 mg,  (a) 30-count bottles (NDC 0093-7809-56) & 90-count bottles (NDC 0093-7809-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "31,079 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "All lots within expiry.  NDC 0093-7809-56 & NDC 0093-7809-98"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81473", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0266-2019", "product_description": "Antacid Tablets, Calcium Carbonate chewable tablets, 750mg, 60-count bottle, OTC, [Healthy Accents brand NDC: 55316-014-72, Distributed by DZA Brands, LLC, Salisbury, NC 28147, Scarborough, ME 04074], [HealthMart Pharmacy brand NDC: 62011-0295-1, Distributed by McKessen, One Post Street, San Francisco, CA 94104], [DG health brand NDC: 55910-717-72, Distributed By Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37072]", "product_quantity": "70,170 bottles", "reason_for_recall": "Presence of foreign substance: Product found to contain metal particles.", "recall_initiation_date": "20181106", "center_classification_date": "20181120", "termination_date": "20200928", "report_date": "20181128", "code_info": "Lots: PA17-412, PA17-077, PA17-196,PA17-127, PA17-150, Exp 11/18", "more_code_info": ""}]